These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 27517672)

  • 1. Low-Dose Mixture Hypothesis of Carcinogenesis Workshop: Scientific Underpinnings and Research Recommendations.
    Miller MF; Goodson WH; Manjili MH; Kleinstreuer N; Bisson WH; Lowe L
    Environ Health Perspect; 2017 Feb; 125(2):163-169. PubMed ID: 27517672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testing the low dose mixtures hypothesis from the Halifax project.
    Goodson WH; Lowe L; Gilbertson M; Carpenter DO
    Rev Environ Health; 2020 Nov; 35(4):333-357. PubMed ID: 32833669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human exposure to chemical mixtures: Challenges for the integration of toxicology with epidemiology data in risk assessment.
    Hernández AF; Tsatsakis AM
    Food Chem Toxicol; 2017 May; 103():188-193. PubMed ID: 28285934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined Exposures and Mixtures Research: An Enduring NIEHS Priority.
    Carlin DJ; Rider CV
    Environ Health Perspect; 2024 Jul; 132(7):75001. PubMed ID: 38968090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should the scope of human mixture risk assessment span legislative/regulatory silos for chemicals?
    Evans RM; Martin OV; Faust M; Kortenkamp A
    Sci Total Environ; 2016 Feb; 543(Pt A):757-764. PubMed ID: 26573369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role of low dose chemical mixtures in adipose tissue in carcinogenesis.
    Lee DH; Jacobs DR; Park HY; Carpenter DO
    Environ Int; 2017 Nov; 108():170-175. PubMed ID: 28863389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental Carcinogenesis and Transgenerational Transmission of Carcinogenic Risk: From Genetics to Epigenetics.
    Burgio E; Piscitelli P; Colao A
    Int J Environ Res Public Health; 2018 Aug; 15(8):. PubMed ID: 30127322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementing Toxicity Testing in the 21st Century (TT21C): Making safety decisions using toxicity pathways, and progress in a prototype risk assessment.
    Adeleye Y; Andersen M; Clewell R; Davies M; Dent M; Edwards S; Fowler P; Malcomber S; Nicol B; Scott A; Scott S; Sun B; Westmoreland C; White A; Zhang Q; Carmichael PL
    Toxicology; 2015 Jun; 332():102-11. PubMed ID: 24582757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of new technologies on human population studies.
    Waters MD; Selkirk JK; Olden K
    Mutat Res; 2003 Nov; 544(2-3):349-60. PubMed ID: 14644337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixture risk assessment and human biomonitoring: Lessons learnt from HBM4EU.
    Luijten M; Vlaanderen J; Kortenkamp A; Antignac JP; Barouki R; Bil W; van den Brand A; den Braver-Sewradj S; van Klaveren J; Mengelers M; Ottenbros I; Rantakokko P; Kolossa-Gehring M; Lebret E
    Int J Hyg Environ Health; 2023 Apr; 249():114135. PubMed ID: 36758443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic and Antagonistic Mutation Responses of Human MCL-5 Cells to Mixtures of Benzo[a]pyrene and 2-Amino-1-Methyl-6-Phenylimidazo[4,5-b]pyridine: Dose-Related Variation in the Joint Effects of Common Dietary Carcinogens.
    David R; Ebbels T; Gooderham N
    Environ Health Perspect; 2016 Jan; 124(1):88-96. PubMed ID: 26091049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of chemical mixtures in public health practice.
    de Rosa CT; El-Masri HA; Pohl H; Cibulas W; Mumtaz MM
    J Toxicol Environ Health B Crit Rev; 2004; 7(5):339-50. PubMed ID: 15371239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alleged misconceptions' distort perceptions of environmental cancer risks.
    Tomatis L; Melnick RL; Haseman J; Barrett JC; Huff J
    FASEB J; 2001 Jan; 15(1):195-203. PubMed ID: 11149907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Toxicology Tools and the Emerging Paradigm Shift in Environmental Health Decision-Making.
    Ginsberg GL; Pullen Fedinick K; Solomon GM; Elliott KC; Vandenberg JJ; Barone S; Bucher JR
    Environ Health Perspect; 2019 Dec; 127(12):125002. PubMed ID: 31834829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Exposure Science: An Emerging Discipline to Support 21st-Century Risk Assessment.
    Egeghy PP; Sheldon LS; Isaacs KK; Özkaynak H; Goldsmith MR; Wambaugh JF; Judson RS; Buckley TJ
    Environ Health Perspect; 2016 Jun; 124(6):697-702. PubMed ID: 26545029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.
    Goodson WH; Lowe L; Carpenter DO; Gilbertson M; Manaf Ali A; Lopez de Cerain Salsamendi A; Lasfar A; Carnero A; Azqueta A; Amedei A; Charles AK; Collins AR; Ward A; Salzberg AC; Colacci A; Olsen AK; Berg A; Barclay BJ; Zhou BP; Blanco-Aparicio C; Baglole CJ; Dong C; Mondello C; Hsu CW; Naus CC; Yedjou C; Curran CS; Laird DW; Koch DC; Carlin DJ; Felsher DW; Roy D; Brown DG; Ratovitski E; Ryan EP; Corsini E; Rojas E; Moon EY; Laconi E; Marongiu F; Al-Mulla F; Chiaradonna F; Darroudi F; Martin FL; Van Schooten FJ; Goldberg GS; Wagemaker G; Nangami GN; Calaf GM; Williams G; Wolf GT; Koppen G; Brunborg G; Lyerly HK; Krishnan H; Ab Hamid H; Yasaei H; Sone H; Kondoh H; Salem HK; Hsu HY; Park HH; Koturbash I; Miousse IR; Scovassi AI; Klaunig JE; Vondráček J; Raju J; Roman J; Wise JP; Whitfield JR; Woodrick J; Christopher JA; Ochieng J; Martinez-Leal JF; Weisz J; Kravchenko J; Sun J; Prudhomme KR; Narayanan KB; Cohen-Solal KA; Moorwood K; Gonzalez L; Soucek L; Jian L; D'Abronzo LS; Lin LT; Li L; Gulliver L; McCawley LJ; Memeo L; Vermeulen L; Leyns L; Zhang L; Valverde M; Khatami M; Romano MF; Chapellier M; Williams MA; Wade M; Manjili MH; Lleonart ME; Xia M; Gonzalez MJ; Karamouzis MV; Kirsch-Volders M; Vaccari M; Kuemmerle NB; Singh N; Cruickshanks N; Kleinstreuer N; van Larebeke N; Ahmed N; Ogunkua O; Krishnakumar PK; Vadgama P; Marignani PA; Ghosh PM; Ostrosky-Wegman P; Thompson PA; Dent P; Heneberg P; Darbre P; Sing Leung P; Nangia-Makker P; Cheng QS; Robey RB; Al-Temaimi R; Roy R; Andrade-Vieira R; Sinha RK; Mehta R; Vento R; Di Fiore R; Ponce-Cusi R; Dornetshuber-Fleiss R; Nahta R; Castellino RC; Palorini R; Abd Hamid R; Langie SA; Eltom SE; Brooks SA; Ryeom S; Wise SS; Bay SN; Harris SA; Papagerakis S; Romano S; Pavanello S; Eriksson S; Forte S; Casey SC; Luanpitpong S; Lee TJ; Otsuki T; Chen T; Massfelder T; Sanderson T; Guarnieri T; Hultman T; Dormoy V; Odero-Marah V; Sabbisetti V; Maguer-Satta V; Rathmell WK; Engström W; Decker WK; Bisson WH; Rojanasakul Y; Luqmani Y; Chen Z; Hu Z
    Carcinogenesis; 2015 Jun; 36 Suppl 1(Suppl 1):S254-96. PubMed ID: 26106142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing uncertainty in risk assessment by using specific knowledge to replace default options.
    McClellan RO
    Drug Metab Rev; 1996; 28(1-2):149-79. PubMed ID: 8744594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.